PPARG and Parkinson disease: For this study, we were particularly interested in one non-thiophilic CBG quinone derivative, so-called VCE-003.2, whose ability to activate PPARγ [19] enables this compound to serve as an anti-inflammatory and a neuroprotectant in LPS-lesioned mice, the experimental model of PD that better reproduces inflammation as a pathogenic event in this disease.